MedPath

Effect of Vaginal Douching With Betadine Before CS for Prevention of Post Operative Infections

Not Applicable
Conditions
Puerperal Infection
Registration Number
NCT03397615
Lead Sponsor
Cairo University
Brief Summary

The present study was a prospective randomized controlled trial in which subjects received a vaginal preparation with povidone-iodine solution immediately prior to caesarean delivery or received no vaginal preparation

Detailed Description

The present study was a prospective randomized controlled trial in which subjects received a vaginal preparation with povidone-iodine solution immediately prior to caesarean delivery or received no vaginal preparation

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
1200
Inclusion Criteria
  • Any patient undergoing CS
Exclusion Criteria
  • • Betadine allegy.

    • Rupture membranes.
    • Accidental Hemorrhage.
    • H/O suggestive chorioamnionitis ; uterine tenderness, offensive vaginal discharge, fever medical disorders as diabetes, hypertension , cardiac or renal diseqases

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Postpartum endometritis6 weeks after Cesarean section

a clinical diagnosis, usually involving fever, uterine fundal tenderness, or prurulent lochia requiring antibiotic therapy.

Secondary Outcome Measures
NameTimeMethod
Postoperative fever3 weeks after Cesarean section

temperature higher than 38 degrees C

Postoperative wound infection6 weeks after Cesarean section

erythema, tenderness, prurulent drainage from the incision site, with or without fever, requiring antibiotic therapy

Trial Locations

Locations (1)

Kasr Alainy medical school

🇪🇬

Cairo, Egypt

Kasr Alainy medical school
🇪🇬Cairo, Egypt
Ahmed Maged, MD
Contact
01005227404
prof.ahmedmaged@gmail.com
Mohamed Nagy, MD
Contact
mnmo75@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.